glp 1 agonist drugs side effects Struggling with GLP-1 therapy effects? You're not alone. This Clinician Guide: Managing Common GLP-1 Receptor Side provides practical tips on recognizing, preventing and managing gastrointestinal and nutritional side effects GLP-1 drugs: Illuminating their full

Research has demonstrated that retatrutide can lead to significant weight loss, with clinical trials showing participants achieving an average weight reduction of X% over a period of Y months

Sarcopenia, or the age-related progressive loss of muscle mass and strength, has serious implications and is becoming more prevalent

16 Through both proactive and ongoing individualized therapy, pharmacists play a central role in mitigating and preventing the GI AEs associated with GLP-1 RA therapy

2025;4:ehae938

78 More recently, in the SURMOUNT-OSA trials, tirzepatide led to substantial weight loss and improved OSA severity, with BP effects that differed depending on concomitant continuous positive airway pressure use (7.6 mm Hg SBP and 2.8 mm Hg DBP reductions in nonusers versus 3.7 mm Hg and 1.1 mm Hg in users)

Toyama M, Watanabe S, Miyauchi T, Kuroda Y, Ojima E, Sato A, et al